Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHORE: Resminostat + FOLFIRI in Advanced Colorectal Carcinoma
NCT01277406Phase 2Completed
- Sponsor
- 4SC AG
- Start
- Jan 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Resminostat in colorectal carcinoma (CRC), sponsored by 4SC AG. Started Jan 2011; status: completed.
02
Drugs
Resminostat
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT01277406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01277406.